Trial Outcomes & Findings for Comparison Effects Of Different Exercise Approaches On Type 2 DM Women (NCT NCT05479435)
NCT ID: NCT05479435
Last Updated: 2025-06-12
Results Overview
Hemoglobin A1c is a blood test used to measure the effectiveness of treatment in diabetes, and sometimes to diagnose diabetes. The generally accepted reference range for Hemoglobin A1c (HbA1c) is between 4% and 6%.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
60 participants
Primary outcome timeframe
Change from Baseline Glycosylated Hemoglobin at 12 weeks.
Results posted on
2025-06-12
Participant Flow
September 1st 2021 started day. The study location was Balikesir Provincial Health Directorate, Edremit District Health Directorates Healthy Life Center, Balikesir, Turkey.
The participiants who diagnosed with Diabetes Mellitus Type 2, were recruited from Balikesir Provincial Health Directorate, Edremit District Health Directorates Healthy Life Center. They were 60 people who were assigned to the groups.
Participant milestones
| Measure |
Blue Prescription Group
Participants will get an exercise program, which is designed by their needs, desires and abilities. They will perform a desired exercise program 3 days a week and they will make an interview for motivation and/or modifying the program one day a week. They will write an activity diary.
Blue Prescription Exercise Program: After the evaluation, DM and physical activity training will be given, the benefits of exercise will be explained and these will be given as a brochure. It will be followed up with the blue prescription program once a week for 12 weeks and will be re-evaluated at the end of the 12th week. Motivation and support will be provided according to the blue prescription philosophy, home exercise program, physical activity selection, obstacles to the activity are discussed, the participant will be asked to determine the appropriate program and keep an activity diary. Throughout the study, the participant will be able to communicate with the physiotherapist by any method (phone, SMS, email).
|
Video Based Home Exercise Group
Participants will get videos by different ways (closed link youtube, whatsapp, flash driver etc.). They will perform exercises 3 days a week. İnvestigator will phone them to ask whether they do the program or not. They will write an activity diary.
Video Based Home Exercise Program: After the evaluation, DM and physical activity training will be given, the benefits of exercise will be explained and these will be given as a brochure. A video exercise program will be given in the format and method desired by the participant. It will be evaluated again at the end of the 12th week.
|
Supervised Exercise Group
Participants will perform an exercise program 3 days a week with a physiotherapist. The group will be held maximum 10 people.
Supervised Group Exercise Program: DM and physical activity training will be given after the assessment, the benefits of the exercise will be explained and these will be given as a brochure. Exercises will be done with a physiotherapist for 12 weeks 3 days a week and will be evaluated again at the end of the 12th week.
|
|---|---|---|---|
|
Overall Study
STARTED
|
20
|
20
|
20
|
|
Overall Study
COMPLETED
|
19
|
20
|
18
|
|
Overall Study
NOT COMPLETED
|
1
|
0
|
2
|
Reasons for withdrawal
| Measure |
Blue Prescription Group
Participants will get an exercise program, which is designed by their needs, desires and abilities. They will perform a desired exercise program 3 days a week and they will make an interview for motivation and/or modifying the program one day a week. They will write an activity diary.
Blue Prescription Exercise Program: After the evaluation, DM and physical activity training will be given, the benefits of exercise will be explained and these will be given as a brochure. It will be followed up with the blue prescription program once a week for 12 weeks and will be re-evaluated at the end of the 12th week. Motivation and support will be provided according to the blue prescription philosophy, home exercise program, physical activity selection, obstacles to the activity are discussed, the participant will be asked to determine the appropriate program and keep an activity diary. Throughout the study, the participant will be able to communicate with the physiotherapist by any method (phone, SMS, email).
|
Video Based Home Exercise Group
Participants will get videos by different ways (closed link youtube, whatsapp, flash driver etc.). They will perform exercises 3 days a week. İnvestigator will phone them to ask whether they do the program or not. They will write an activity diary.
Video Based Home Exercise Program: After the evaluation, DM and physical activity training will be given, the benefits of exercise will be explained and these will be given as a brochure. A video exercise program will be given in the format and method desired by the participant. It will be evaluated again at the end of the 12th week.
|
Supervised Exercise Group
Participants will perform an exercise program 3 days a week with a physiotherapist. The group will be held maximum 10 people.
Supervised Group Exercise Program: DM and physical activity training will be given after the assessment, the benefits of the exercise will be explained and these will be given as a brochure. Exercises will be done with a physiotherapist for 12 weeks 3 days a week and will be evaluated again at the end of the 12th week.
|
|---|---|---|---|
|
Overall Study
Withdrawal by Subject
|
1
|
0
|
0
|
|
Overall Study
Covid 19
|
0
|
0
|
2
|
Baseline Characteristics
From blue prescription group, one participant had took COVID 19, from supervised group, one participant had took COVID 19 and the other wanted to drop off by herself. So we drop off them.
Baseline characteristics by cohort
| Measure |
Blue Prescription Group
n=20 Participants
Participants will get an exercise program, which is designed by their needs, desires and abilities. They will perform a desired exercise program 3 days a week and they will make an interview for motivation and/or modifying the program one day a week. They will write an activity diary.
Blue Prescription Exercise Program: After the evaluation, DM and physical activity training will be given, the benefits of exercise will be explained and these will be given as a brochure. It will be followed up with the blue prescription program once a week for 12 weeks and will be re-evaluated at the end of the 12th week. Motivation and support will be provided according to the blue prescription philosophy, home exercise program, physical activity selection, obstacles to the activity are discussed, the participant will be asked to determine the appropriate program and keep an activity diary. Throughout the study, the participant will be able to communicate with the physiotherapist by any method (phone, SMS, email).
|
Video Based Home Exercise Group
n=20 Participants
Participants will get videos by different ways (closed link youtube, whatsapp, flash driver etc.). They will perform exercises 3 days a week. İnvestigator will phone them to ask whether they do the program or not. They will write an activity diary.
Video Based Home Exercise Program: After the evaluation, DM and physical activity training will be given, the benefits of exercise will be explained and these will be given as a brochure. A video exercise program will be given in the format and method desired by the participant. It will be evaluated again at the end of the 12th week.
|
Supervised Exercise Group
n=20 Participants
Participants will perform an exercise program 3 days a week with a physiotherapist. The group will be held maximum 10 people.
Supervised Group Exercise Program: DM and physical activity training will be given after the assessment, the benefits of the exercise will be explained and these will be given as a brochure. Exercises will be done with a physiotherapist for 12 weeks 3 days a week and will be evaluated again at the end of the 12th week.
|
Total
n=60 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
52.68 years
STANDARD_DEVIATION 9.08 • n=20 Participants
|
48.85 years
STANDARD_DEVIATION 8.79 • n=20 Participants
|
50.39 years
STANDARD_DEVIATION 8.46 • n=20 Participants
|
50.61 years
STANDARD_DEVIATION 8.77 • n=60 Participants
|
|
Sex: Female, Male
Female
|
20 Participants
n=20 Participants • From blue prescription group, one participant had took COVID 19, from supervised group, one participant had took COVID 19 and the other wanted to drop off by herself. So we drop off them.
|
20 Participants
n=20 Participants • From blue prescription group, one participant had took COVID 19, from supervised group, one participant had took COVID 19 and the other wanted to drop off by herself. So we drop off them.
|
20 Participants
n=20 Participants • From blue prescription group, one participant had took COVID 19, from supervised group, one participant had took COVID 19 and the other wanted to drop off by herself. So we drop off them.
|
60 Participants
n=60 Participants • From blue prescription group, one participant had took COVID 19, from supervised group, one participant had took COVID 19 and the other wanted to drop off by herself. So we drop off them.
|
|
Sex: Female, Male
Male
|
0 Participants
n=20 Participants • From blue prescription group, one participant had took COVID 19, from supervised group, one participant had took COVID 19 and the other wanted to drop off by herself. So we drop off them.
|
0 Participants
n=20 Participants • From blue prescription group, one participant had took COVID 19, from supervised group, one participant had took COVID 19 and the other wanted to drop off by herself. So we drop off them.
|
0 Participants
n=20 Participants • From blue prescription group, one participant had took COVID 19, from supervised group, one participant had took COVID 19 and the other wanted to drop off by herself. So we drop off them.
|
0 Participants
n=60 Participants • From blue prescription group, one participant had took COVID 19, from supervised group, one participant had took COVID 19 and the other wanted to drop off by herself. So we drop off them.
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
Turkey
|
20 Participants
n=20 Participants
|
20 Participants
n=20 Participants
|
20 Participants
n=20 Participants
|
60 Participants
n=60 Participants
|
PRIMARY outcome
Timeframe: Change from Baseline Glycosylated Hemoglobin at 12 weeks.Hemoglobin A1c is a blood test used to measure the effectiveness of treatment in diabetes, and sometimes to diagnose diabetes. The generally accepted reference range for Hemoglobin A1c (HbA1c) is between 4% and 6%.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Glycosylated Hemoglobin Change
Baseline
|
6.82 percentage of glycosylated hemoglobin
Standard Deviation 1.21
|
7.17 percentage of glycosylated hemoglobin
Standard Deviation 2.37
|
6.80 percentage of glycosylated hemoglobin
Standard Deviation 0.94
|
|
Glycosylated Hemoglobin Change
At the end of 12 weeks
|
6.33 percentage of glycosylated hemoglobin
Standard Deviation 0.94
|
6.69 percentage of glycosylated hemoglobin
Standard Deviation 2.08
|
6.32 percentage of glycosylated hemoglobin
Standard Deviation 0.91
|
PRIMARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks)The questionnaire provides information about the time spent by the individual in light, moderate, and vigorous activities and sitting in the last 7 days. The MET-min / week score is obtained by multiplying the MET value (metabolic equivalent) by days and minutes for each activity level. Physical activity levels are classified as: Physically inactive (\<600 MET-min / week), Low physical activity (600-3000 MET-min / week), and Adequate physical activity (\> 3000 MET-min / week). A higher score is associated with a higher physical activity level.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Physical Activity Level Change
baseline
|
846.45 MET-min / week
Standard Deviation 615.04
|
797.20 MET-min / week
Standard Deviation 635.14
|
909.64 MET-min / week
Standard Deviation 699.90
|
|
Physical Activity Level Change
at the end of the 12 weeks
|
1960.89 MET-min / week
Standard Deviation 735.78
|
1654.05 MET-min / week
Standard Deviation 770.22
|
2370.11 MET-min / week
Standard Deviation 772.45
|
PRIMARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks)The participant will sit on a chair without armrests, stand up with the command to start, walk 3 meters towards the designated point, turn around and walk to the starting point again and sit. The test is repeated 3 times and the average is taken. The time will be recorded in seconds. As time increases, the risk of falling increases.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Functional Capacity Change With Timed Up And Go Test
baseline
|
10.64 second
Standard Deviation 1.80
|
10.31 second
Standard Deviation 1.74
|
10.62 second
Standard Deviation 1.71
|
|
Functional Capacity Change With Timed Up And Go Test
at the end of the 12 weeks
|
9.21 second
Standard Deviation 1.29
|
8.99 second
Standard Deviation 1.51
|
9.26 second
Standard Deviation 1.37
|
PRIMARY outcome
Timeframe: Change from Baseline 6-minute Walking Test Results at 12 weeks.It will be performed in a 30 meter long corridor or in an open area. The participant will be asked to walk without running at the highest speed for 6 minutes. Before and during the march, the participant will be verbally encouraged and motivated. How many meters they walked will be recorded as a result of the test. Six-minute walk test results can be interpreted as follows: Normal: more than 500 meters Light restriction: 400 to 500 meters Moderate restriction: 300 to 400 meters Severe restriction: between 200 - 300 meters Serious restriction: less than 200 meters.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Functional Capacity Change With 6-minute Walking Test
baseline
|
402.57 meter
Standard Deviation 38.52
|
405.95 meter
Standard Deviation 44.84
|
416.97 meter
Standard Deviation 49.66
|
|
Functional Capacity Change With 6-minute Walking Test
at the end of the 12 weeks
|
462.82 meter
Standard Deviation 44.38
|
457.85 meter
Standard Deviation 55.35
|
483.44 meter
Standard Deviation 55.32
|
PRIMARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).Measured level of glucose in the blood after 8 to 12 hours of fasting. The unit of measurement is mg/dL, the reference range is 70-110 mg/dL.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Fasting Plasma Glucose
baseline
|
138.21 (mg/dL)
Standard Deviation 34.49
|
157.05 (mg/dL)
Standard Deviation 60.90
|
128.33 (mg/dL)
Standard Deviation 25.02
|
|
Fasting Plasma Glucose
at the end of the 12 weeks
|
115.53 (mg/dL)
Standard Deviation 22.48
|
145.50 (mg/dL)
Standard Deviation 43.73
|
118.28 (mg/dL)
Standard Deviation 20.57
|
PRIMARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).It takes part in the transport of cholesterol from tissues and vessels to the liver and in the synthesis of vitamin D. The unit of measurement is mg/dL, the reference range is 30-96 mg/dL.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
High Density Lipoprotein
baseline
|
52.74 mg/dL
Standard Deviation 11.11
|
54.30 mg/dL
Standard Deviation 10.31
|
54.83 mg/dL
Standard Deviation 20.80
|
|
High Density Lipoprotein
at the end of the 12 weeks
|
59.05 mg/dL
Standard Deviation 11.26
|
59.20 mg/dL
Standard Deviation 10.50
|
62.53 mg/dL
Standard Deviation 19.23
|
PRIMARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).It provides the transport of cholesterol synthesized in the liver to the tissues and blood vessels. The unit of measurement is mg/dL, the reference range is 0- 130 mg/dL.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Low Density Lipoprotein
baseline
|
136.58 mg/dL
Standard Deviation 33.62
|
123.45 mg/dL
Standard Deviation 24.57
|
156.00 mg/dL
Standard Deviation 67.90
|
|
Low Density Lipoprotein
at the end of the 12 weeks
|
125.37 mg/dL
Standard Deviation 31.55
|
116.90 mg/dL
Standard Deviation 20.79
|
130.33 mg/dL
Standard Deviation 39.47
|
PRIMARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).Total cholesterol is a value that shows the total amount of cholesterol in the blood. In addition to LDL and HDL, triglyceride levels are also used to calculate total cholesterol. The unit of measurement is mg/dL, the reference range is 70-200 mg/dL.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Total Cholesterol
baseline
|
219.21 mg/dL
Standard Deviation 46.28
|
208.40 mg/dL
Standard Deviation 33.36
|
221.28 mg/dL
Standard Deviation 31.84
|
|
Total Cholesterol
at the end of the 12 weeks
|
203.00 mg/dL
Standard Deviation 43.61
|
189.90 mg/dL
Standard Deviation 28.55
|
200.61 mg/dL
Standard Deviation 27.89
|
PRIMARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).It is a storage nutrient molecule formed by the combination of fatty acids and glycerol molecules, which form the structure of fats in foods. The unit of measurement is mg/dL, the reference range is 0-250 mg/dL.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Triglyceride
baseline
|
173.16 mg/dL
Standard Deviation 58.50
|
172.15 mg/dL
Standard Deviation 36.08
|
203.12 mg/dL
Standard Deviation 139.64
|
|
Triglyceride
at the end of the 12 weeks
|
156.00 mg/dL
Standard Deviation 54.29
|
152.85 mg/dL
Standard Deviation 38.48
|
184.22 mg/dL
Standard Deviation 109.60
|
PRIMARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).It is a protein produced in the liver. It is a protein that is produced by cells and secreted into the blood when the body reacts to conditions such as infection, tumor, trauma, and undertakes various biochemical tasks. The unit of measurement is mg/dL, the reference range is 0-0.5 mg/dL.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
C-reactive Protein
at the end of the 12 weeks
|
1.83 mg/dL
Standard Deviation 2.95
|
1.51 mg/dL
Standard Deviation 1.03
|
2.46 mg/dL
Standard Deviation 2.55
|
|
C-reactive Protein
baseline
|
2.31 mg/dL
Standard Deviation 3.63
|
1.55 mg/dL
Standard Deviation 1.25
|
3.51 mg/dL
Standard Deviation 4.12
|
PRIMARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).Blood pressure is the pressure that builds up in the blood vessels when the heart contracts. It is measured with a sphygmomanometer. The cuff is placed 2.5 to 3 cm above the inside of the elbow. The stethoscope is placed under the cuff and pressed lightly. The sphygmomanometer cuff is then inflated to 20 to 30 mmHg above the level at which the pulse disappears. The control valve should be opened slightly, and air should be vented at a rate of 2-4 mmHg per second. The first sound heard as the air is released determines the systolic blood pressure. The reference range averages 120 - 130 mmHg.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Systolic Blood Pressure
baseline
|
128.63 mmHg
Standard Deviation 8.32
|
129.05 mmHg
Standard Deviation 8.25
|
134.78 mmHg
Standard Deviation 7.80
|
|
Systolic Blood Pressure
at the end of the 12 weeks
|
123.63 mmHg
Standard Deviation 7.82
|
126.30 mmHg
Standard Deviation 7.76
|
129.17 mmHg
Standard Deviation 6.40
|
PRIMARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).The pressure that builds up in the blood vessels as the heart relaxes is known as diastolic blood pressure. It is measured using a sphygmomanometer, which is placed 2.5 to 3 cm above the inside of the elbow. The stethoscope is placed under the cuff and lightly pressed. The sphygmomanometer cuff is then inflated to 20 to 30 mmHg above the point where the pulse disappears. The control valve should be opened slightly, and air should be released at a rate of 2-4 mmHg per second. The point at which the sound becomes inaudible is considered the diastolic blood pressure. The reference range averages 70 - 90 mmHg.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Diastolic Blood Pressure
baseline
|
77.05 mmHg
Standard Deviation 8.08
|
80.10 mmHg
Standard Deviation 6.16
|
83.50 mmHg
Standard Deviation 6.72
|
|
Diastolic Blood Pressure
at the end of the 12 weeks
|
75.47 mmHg
Standard Deviation 7.24
|
78.85 mmHg
Standard Deviation 6.01
|
81.39 mmHg
Standard Deviation 6.43
|
PRIMARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).It is the value that shows how many times the heart beats in a minute. Measurement from the wrist: measured from the radial artery with 3 fingers with the palm facing up. The reference range is between 60 and 100 beats per minute (bpm).
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Heart Rate
baseline
|
72.63 beats/min
Standard Deviation 7.30
|
73.70 beats/min
Standard Deviation 6.28
|
76.56 beats/min
Standard Deviation 5.55
|
|
Heart Rate
at the end of the 12 weeks
|
71.16 beats/min
Standard Deviation 6.10
|
72.30 beats/min
Standard Deviation 5.11
|
74.11 beats/min
Standard Deviation 4.20
|
SECONDARY outcome
Timeframe: Change from Baseline Bioelectrical Impedance Analysis at 12 weeks.-Bioelectrical Impedance Analysis (BIA): The basic principle is to measure the impedance by using the resistance and conductivity that a very small amount of electrical current encounters when passing through tissues. Reference values for Bioelectrical Impedance Analysis (BIA) may vary depending on factors such as age, gender, height and weight. However, a typical BIA reference range for generally healthy adults is as follows: Body Fat Percentage: For women: 20% - 25% Body Mass Index (BMI): Normal Range: 18.5 - 24.9 kg/m² However, these values can vary greatly between individuals and may vary depending on many factors such as clinical conditions, lifestyle factors, ethnicity, etc. Therefore, BIA results should be interpreted taking into account the individual's personal health status and goals. "Tanita SC-330" brand device will be used in our study.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Body Fat Ratio Change With Bioelectrical Impedance Analysis (BIA)
baseline
|
43.63 percent body fat
Standard Deviation 4.86
|
40.27 percent body fat
Standard Deviation 4.53
|
43.54 percent body fat
Standard Deviation 4.04
|
|
Body Fat Ratio Change With Bioelectrical Impedance Analysis (BIA)
at the end of the 12 weeks
|
41.79 percent body fat
Standard Deviation 5.04
|
38.30 percent body fat
Standard Deviation 4.77
|
41.06 percent body fat
Standard Deviation 4.15
|
SECONDARY outcome
Timeframe: Change from Baseline Skinfold Analysis at 12 weeks.All measurements will be made on the right side of the body. The caliper will be placed approximately 1 cm from the thumb and index finger, and 1-2 seconds will be waited before the caliper is read. Body fat percentages of individuals will be calculated using Jackson-Pollock 7 region equations; Triceps, Subscapularis, Midaxillary, Abdominal, Chest, Suprailiac. The Jackson-Pollock skinfold thickness method is a method used to estimate body fat percentage. Reference values may vary depending on factors such as the person's gender, age range and lifestyle. However, in general, reference values for body fat percentage obtained using the Jackson-Pollock formula are as follows: Athletic women: 14-20% Women in good shape: 21-24% Average women: 25-31% Overweight women: 32-39% Obese women: 40% and above
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Body Fat Ratio Change With Skinfold Analysis
baseline
|
42.76 percent body fat
Standard Deviation 3.04
|
41.59 percent body fat
Standard Deviation 3.39
|
43.36 percent body fat
Standard Deviation 1.95
|
|
Body Fat Ratio Change With Skinfold Analysis
at the end of the 12 weeks
|
41.85 percent body fat
Standard Deviation 3.19
|
40.78 percent body fat
Standard Deviation 3.36
|
42.55 percent body fat
Standard Deviation 2.10
|
SECONDARY outcome
Timeframe: Change from Baseline Fingertip-to-floor Distance Measure at 12 weeks.During the test, the participant will be asked to lean forward without bending their knees and try to touch the fingertip. The distance between the tip of the third finger of the hand and the ground will be measured and the result will be recorded in cm. This distance is considered normal up to 0 cm in women and up to 10 cm in men.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Flexibility Change With Fingertip-to-floor Distance Measure
baseline
|
9.05 centimeter
Standard Deviation 4.08
|
10.90 centimeter
Standard Deviation 8.90
|
9.67 centimeter
Standard Deviation 5.79
|
|
Flexibility Change With Fingertip-to-floor Distance Measure
at the end of the 12 weeks
|
4.16 centimeter
Standard Deviation 4.51
|
7.70 centimeter
Standard Deviation 7.23
|
5.67 centimeter
Standard Deviation 4.28
|
SECONDARY outcome
Timeframe: Change from Baseline Trunk Lateral Flexion Measure at 12 weeks.The participant will be asked to stand with their feet slightly open, parallel to each other, arms next to the trunk. Mark the distal end of the third finger of the hand on the thigh, and the participant will be asked to perform lateral flexion. The point where the distal of the third finger comes from is marked again. The distance between the two points is cm. will be recorded in terms. A higher value is associated with good flexibility.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Flexibility Change With Trunk Lateral Flexion Measure
baseline
|
12.95 centimeter
Standard Deviation 3.31
|
13.68 centimeter
Standard Deviation 4.19
|
12.61 centimeter
Standard Deviation 3.50
|
|
Flexibility Change With Trunk Lateral Flexion Measure
at the end of the 12 weeks
|
17.47 centimeter
Standard Deviation 3.29
|
17.15 centimeter
Standard Deviation 4.22
|
18.89 centimeter
Standard Deviation 2.91
|
SECONDARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).The Diabetes Quality of Life (DQoL) Questionnaire consists of 46 items divided into four subscales: Satisfaction (15 items), Impact (20 items), Worry - Social/Vocational (7 items), and Worry - Diabetes-Related (4 items). Each item is rated on a 5-point Likert scale ranging from 1 to 5. Depending on the item, higher scores may indicate either greater dissatisfaction, greater impact, or higher worry. Subscale scores are calculated by summing item responses within each subscale. The total score is the sum of all items and ranges from 46 to 230. Higher total scores indicate a lower diabetes-related quality of life.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Life Quality
baseline
|
3.57 units on a scale
Standard Deviation 0.58
|
3.61 units on a scale
Standard Deviation 0.51
|
3.61 units on a scale
Standard Deviation 0.45
|
|
Life Quality
at the end of the 12 weeks
|
4.31 units on a scale
Standard Deviation 0.33
|
4.29 units on a scale
Standard Deviation 0.30
|
4.60 units on a scale
Standard Deviation 0.24
|
SECONDARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).It will be evaluated with the Beck Depression Scale. The scale is used to measure the level of depression with a 21-item multiple-choice question. Each question is evaluated within a certain score range, and the total score shows the person's depression level. However, the scale does not have an official "reference" range because scoring may vary depending on clinical or research purposes. In general, Beck Depression Inventory (BDI) scores can be interpreted as follows: 0-13 points: Mild or minimal depression 14-19 points: Mild depression 20-28 points: Moderate depression 29-63 points: Severe depression
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Depression
baseline
|
12.95 units on a scale
Standard Deviation 7.42
|
13.15 units on a scale
Standard Deviation 4.66
|
16.17 units on a scale
Standard Deviation 5.22
|
|
Depression
at the end of the 12weeks
|
9.37 units on a scale
Standard Deviation 5.24
|
9.65 units on a scale
Standard Deviation 4.13
|
9.78 units on a scale
Standard Deviation 4.41
|
SECONDARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).It will be evaluated with The Diabetes Treatment Satisfaction Questionnaire (DTSQ). The questionnaire measures how the individual perceives glycemic control and satisfaction with the treatment. Suitable for Type 1 DM and Type 2 DM. It consists of 8 items and is scored on a 0-6 Likert scale. 6 items 1, 4, 5, 6, 7, 8); It meets to determine satisfaction between 0 (not at all) and 6 (very satisfied). Of the remaining items, 2, 0 (never) to 6 almost always) measure the frequency of detection of hyperglycemia, and item 3 measures the frequency of detecting hypoglycemia. The highest score is calculated as 36. High scores indicate satisfaction with treatment, while low scores indicate dissatisfaction.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Contentment
baseline
|
21.37 units on a scale
Standard Deviation 4.03
|
22.30 units on a scale
Standard Deviation 4.73
|
19.28 units on a scale
Standard Deviation 4.90
|
|
Contentment
at the end of the 12 weeks
|
29.63 units on a scale
Standard Deviation 2.03
|
29.75 units on a scale
Standard Deviation 2.65
|
32.17 units on a scale
Standard Deviation 1.58
|
SECONDARY outcome
Timeframe: In the beginning of the interventionIt will be measured with a stadiometer. Head, shoulders, back, hips, calves and heels will touch the stadiometer, stand upright with feet shoulder-width apart, slide of height meter will be pulled down.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Height
|
1.57 meter
Standard Deviation 0.06
|
1.58 meter
Standard Deviation 0.05
|
1.59 meter
Standard Deviation 0.05
|
SECONDARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).It will be measured with a standard weighing instrument.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Weight
baseline
|
88.55 kg
Standard Deviation 12.81
|
79.87 kg
Standard Deviation 11.65
|
87.93 kg
Standard Deviation 13.14
|
|
Weight
at the end of the 12 weeks
|
84.69 kg
Standard Deviation 10.86
|
77.96 kg
Standard Deviation 11.07
|
81.40 kg
Standard Deviation 11.82
|
SECONDARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).In the anatomical position, the tape measure is measured just below the thyroid cartilage.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Neck Circumference
baseline
|
38.13 centimeter
Standard Deviation 2.80
|
38.05 centimeter
Standard Deviation 3.02
|
38.53 centimeter
Standard Deviation 2.84
|
|
Neck Circumference
at the end of the 12 weeks
|
37.05 centimeter
Standard Deviation 2.46
|
36.95 centimeter
Standard Deviation 2.82
|
36.83 centimeter
Standard Deviation 2.15
|
SECONDARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).It is measured at the thinnest point between the lowest rib and anterior superior to the processus spina ilica in the anatomical position.
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Waist Circumference
baseline
|
104.42 centimeter
Standard Deviation 14.45
|
103.10 centimeter
Standard Deviation 12.54
|
109.56 centimeter
Standard Deviation 10.26
|
|
Waist Circumference
at the end of the 12 weeks
|
100.16 centimeter
Standard Deviation 13.00
|
98.60 centimeter
Standard Deviation 12.65
|
102.78 centimeter
Standard Deviation 8.02
|
SECONDARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).Measured at the widest point of the Gluteus Maximus muscle in the anatomical position
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Hip Circumference
baseline
|
120.58 centimeter
Standard Deviation 12.13
|
113.60 centimeter
Standard Deviation 7.96
|
116.72 centimeter
Standard Deviation 8.72
|
|
Hip Circumference
at the end of the 12 weeks
|
117.84 centimeter
Standard Deviation 11.33
|
111.90 centimeter
Standard Deviation 7.97
|
112.17 centimeter
Standard Deviation 7.83
|
SECONDARY outcome
Timeframe: In the beginning of the intervention and at the end of the exercise program (12 weeks).BMI will be calculated by dividing body weight (kg) by height square (m\^2). General reference ranges for BMI are as follows: If BMI is less than 18.5 kg/m\^2: Underweight If BMI is between 18.5-24.9 kg/m\^2: Normal weight If BMI is between 25.0-29.9 kg/m\^2: Overweight If BMI is 30.0 kg/m\^2 and above: Obese
Outcome measures
| Measure |
Blue Prescription Group
n=19 Participants
Participants will receive an exercise program tailored to their needs, desires, and abilities. They will engage in this program three days a week and participate in motivational interviews or program modification sessions once a week. Additionally, they will maintain an activity diary.
As part of the Blue Prescription Exercise Program, participants will undergo an evaluation followed by diabetes and physical activity training. They will also receive a brochure explaining the benefits of exercise. The Blue Prescription program will be followed once a week for 12 weeks, with a re-evaluation at the end of this period. Motivation and support will align with the Blue Prescription philosophy, incorporating a home exercise program, discussing physical activity selection, and addressing obstacles. Participants will be encouraged to determine the most suitable program and keep an activity diary. Throughout the study, participants will have the option to communicate with the physiotherapist via phone, SMS, or email.
|
Video Based Home Exercise Group
n=20 Participants
Participants will receive videos through various channels for their exercise program. They will engage in these exercises three days a week. An investigator will contact them via phone to inquire whether they are following the program. Additionally, participants will maintain an activity diary.
Video-Based Home Exercise Program: Following an evaluation, participants will receive training on diabetes management and physical activity. They will be provided with a brochure explaining the benefits of exercise. The exercise program will be delivered in video format, tailored to the participant's preferences and chosen method of delivery. A re-evaluation will be conducted at the end of the 12th week
|
Supervised Exercise Group
n=18 Participants
Participants will engage in a supervised group exercise program led by a physiotherapist, with a maximum of 10 people per group. Following an assessment, participants will receive training on diabetes management and physical activity. The benefits of exercise will be explained and provided in brochure format.
The supervised group exercise sessions will take place three days a week for a duration of 12 weeks. At the end of the 12-week period, participants will undergo a re-evaluation.
|
|---|---|---|---|
|
Body Mass Index (BMI)
baseline
|
35.93 kg/m^2
Standard Deviation 5.73
|
32.04 kg/m^2
Standard Deviation 5.04
|
34.76 kg/m^2
Standard Deviation 5.03
|
|
Body Mass Index (BMI)
at the end of the 12 weeks
|
34.36 kg/m^2
Standard Deviation 4.95
|
31.24 kg/m^2
Standard Deviation 4.74
|
32.32 kg/m^2
Standard Deviation 4.53
|
Adverse Events
Blue Prescription Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Video Based Home Exercise Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Supervised Exercise Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place